Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves’ disease
Abstract
Summary: Objective Differentiation between destruction‐induced thyrotoxicosis and Graves’ thyrotoxicosis is important for selection of proper therapy. It is, however, often difficult to make this distinction without measurement of radioactive iodine uptake. We investigated the possibility that assessment of thyroid blood flow would allow differentiation between the two entities. Patients and measurements One hundred and fourteen untreated patients with thyrotoxicosis (56 Graves’ disease, 28 painless thyroiditis, 30 subacute thyroiditis) and 25 normal controls were examined. Serum levels of freeT4 (FT4), freeT3 (FT3) and TSH were measured by chemiluminescent immunoassay, and anti‐TSH receptor antibodies (TSH‐binding inhibitory immunoglobulin, TBII) were measured by enzyme‐linked immunosorbent assay. Thyroid volume and blood flow (TBF) were measured quantitatively by ultrasonography. Results TBF was significantly higher in Graves’ disease (mean ± 1SD: 14·9 ± 6·4%, P < 0·0001) than in painless thyroiditis (0·8 ± 0·5%), subacute thyroiditis (0·9 ± 0·7%) and in normal controls (0·8 ± 0·5%). All patients with Graves’ disease had TBF values of more than 4% and all patients with painless thyroiditis and subacute thyroiditis had TBF values less than 4%. TBF values significantly correlated with values of radioactive iodine uptake (RAIU) either at 3 h (r = 0·492, P < 0·01) or 24 h (r = 0·762, P < 0·001) within the Graves’ disease and painless thyroiditis groups. There was no relationship between TBF values and thyroid volumes or values of TBII in the Graves’ disease group. All patients with Graves’ disease had positive TBII of 15% or more. Three of 28 patients with painless thyroiditis and one of 30 patients with subacute thyroiditis had positive TBII. Conclusion TBF was quantitatively measured by power Doppler ultrasonography and was more effective than TBII for differentiation between destruction‐induced thyrotoxicosis (painless or subacute thyroiditis) and Graves’ thyrotoxicosis. TBF values of less than 4% in untreated thyrotoxic patients are laboratory signals of destruction‐induced thyrotoxicosis and if these are determined, the radioactive iodine uptake test can be omitted for differential diagnosis of these two types of thyrotoxicosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Thyroid color Doppler ultrasonography may assist in distinguishing between destructive thyroiditis and GD.
“If needed, thyroid color Doppler ultrasonography may assist in distinguishing between destructive thyroiditis and GD (508,512,513).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [512]
Cites
Werner and Ingbar's The Thyroid
Meier, D. A. (1997) · Clinical Nuclear Medicine · doi:10.1097/00003072-199710000-00025 · Cited by 401 · see citing works
Costagliola, S., Morgenthaler, N. G., Hoermann, R., Badenhoop, K. W. J., Struck, J., Freitag, D., Poertl, S., Weglöhner, W., Hollidt, J. M., Quadbeck, B., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5415 · Cited by 341 · see citing works
Color-flow Doppler sonography in Graves disease: "thyroid inferno"
Ralls, P., Mayekawa, D. S., Lee, K. P., Colletti, P., Radin, D., BOSWELL, W. D., & Halls, J. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.4.781 · Cited by 221 · see citing works
AMINO, N., YABU, Y., MIKI, T., MORIMOTO, S., KUMAHARA, Y., MORI, H., IWATANI, Y., NISHI, K., NAKATANI, K., & MIYAI, K. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-113 · Cited by 149 · see citing works
Self-citationBogazzi, F., Bartalena, L., Brogioni, S., Burelli, A., Manetti, L., Tanda, M. L., Gasperi, M., & Martino, E. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400452 · Cited by 135 · see citing works
Detecting TSH-Receptor Antibodies with the Recombinant TBII Assay: Technical and Clinical Evaluation
Schott, M., Feldkamp, J., Bathan, C., Fritzen, R., Scherbaum, W., & Seißler, J. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978666 · Cited by 99 · see citing works
Murakami, Y., Takamatsu, J., Sakane, S., Kuma, K., & Ohsawa, N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784079 · Cited by 99 · see citing works
Morita, T., Tamai, H., Oshima, A., Mukuta, T., Fukata, S., Kuma, K., Kumagai, L. F., & Nagataki, S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-1051 · Cited by 95 · see citing works
Self-citationKamijo, K. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.113 · Cited by 86 · see citing works
DIFFERENTIATION OF THYROTOXICOSIS INDUCED BY THYROID DESTRUCTION FROM GRAVES' DISEASE
Amino, N., Miyai, K., AZUKIZAWA, M., YABU, Y., Fujie, T., Onishi, T., & Kumahara, Y. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92943-4 · Cited by 82 · see citing works
Self-citationBogazzi, F., Martino, E., Dell’Unto, E., Brogioni, S., Cosci, C., Aghini-Lombardi, F., Ceccarelli, C., Pinchera, A., Bartalena, L., & Braverman, L. E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347021 · Cited by 71 · see citing works
Izumi, Y., Hidaka, Y., Tada, H., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01558.x · Cited by 70 · see citing works
The Spectrum of Postpartum Thyroid Dysfunction: Diagnosis, Management, and Long-Term Prognosis
Amino, N., Tada, H., & Hidaka, Y. (1996) · Endocrine Practice · doi:10.4158/ep.2.6.406 · Cited by 59 · see citing works
Self-citationMeasurement of Thyroid Blood Flow Area Is Useful for Diagnosing the Cause of Thyrotoxicosis
Kurita, S., Sakurai, M., Kita, Y., Ota, T., Ando, H., Kaneko, S., & Takamura, T. (2005) · Thyroid · doi:10.1089/thy.2005.15.1249 · Cited by 56 · see citing works
Noh, J. Y., Momotani, N., Fukada, S., Ito, K., Miyauchi, A., & Amino, N. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.537 · Cited by 55 · see citing works
Self-citationPostpartum Autoimmune Thyroid Syndrome.
Amino, N., Tada, H., Hidaka, Y., & Izumi, Y. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.645 · Cited by 53 · see citing works
Self-citationIitaka, M., Morgenthaler, N. G., Momotani, N., et al. (2003) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01939.x · Cited by 52 · see citing works
KASHIWAI, T., Hidaka, Y., Takano, T., Tatsumi, K.-I., Izumi, Y., Shimaoka, Y., Tada, H., Takeoka, K., & Amino, N. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.45 · Cited by 38 · see citing works
Self-citationRadionuclide administration to nursing mothers: mathematically derived guidelines.
Romney, B. M., Nickoloff, E. L., Esser, P. D., & Alderson, P. O. (1986) · Radiology · doi:10.1148/radiology.160.2.3726137 · Cited by 34 · see citing works
Kasagi, K., Kousaka, T., Misaki, T., Iwata, M., Alam, M. S., & Konishi, J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00632.x · Cited by 27 · see citing works
SAYAMA, N., Yoshida, K., Mori, K., et al. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.767 · Cited by 22 · see citing works
Technetium Tc 99m Uptake in Postpartum Thyrotoxicosis
Lervang, H.-H. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370050186036 · Cited by 4 · see citing works
Technetium Tc 99m uptake in postpartum thyrotoxicosis
Lervang, H.-H. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.5.994 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883 · see citing works
Clinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237 · see citing works
Kahaly, G. J., Bartalena, L., & Hegedüs, L. (2011) · Thyroid® · doi:10.1089/thy.2011.2106.ed3 · Cited by 80 · see citing works
Ide, A., Amino, N., Kang, S., Yoshioka, W., Kudo, T., Nishihara, E., Ito, M., Nakamura, H., & Miyauchi, A. (2014) · Thyroid® · doi:10.1089/thy.2013.0585 · Cited by 56 · see citing works
Self-citationBogazzi, F., & Vitti, P. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0692 · Cited by 46 · see citing works
- Authors
- Ota, H., Amino, N., Morita, S., Kobayashi, K., Kubota, S., Fukata, S., Kamiyama, N., & Miyauchi, A.
- Affiliations
- Kuma Hospital (JP)
- Toshiba (Japan) (JP)
- Corresponding author
- Amino, Nobuyuki
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2007-04-27
- Volume
- 67
- Issue
- 1
- Pages
- 41-45
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1983011372
- Cited by
- 144
- References
- 23
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 36 · 2022: 6 · 2021: 2 · 2020: 7 · 2019: 6 · 2018: 2 · 2017: 8 · 2016: 5 · 2015: 4 · 2014: 4 · 2013: 11 · 2012: 12
- FWCI
- 4.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
- Keywords
- thyroid blood flow, painless thyroiditis, subacute thyroiditis, Graves' disease, thyrotoxicosis, differential diagnosis, power Doppler, TSH-binding inhibitory immunoglobulin, radioiodine uptake, thyroid volume, TSH receptor antibodies, thyroid destruction, thyroid hormone levels, thyroid-stimulating hormone, T3, thyroxine, treatment selection
- MeSH terms
- Adolescent, Adult, Aged, Diagnosis, Differential, Female, Graves Disease, Humans, Iodine Radioisotopes, Male, Middle Aged, Radionuclide Imaging, Regional Blood Flow, Thyroid Function Tests, Thyroid Gland, Thyroid Hormones, Thyroiditis, Linear Models, Case-Control Studies, Ultrasonography, Doppler, Pulsed, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review